FDA Grants Accelerated Approval for First Treatment for Barth Syndrome, Forzinity

THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first treatment for Barth syndrome.
Barth syndrome is a rare, serious, and life-threatening disease of the...